Autopsy report · NCT00372996
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Cause of deathFunding or business, also safety
“This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature closure was not prompted by any safety or efficacy concerns.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 7 years 4 months before it stopped.
- 219 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Breast Neoplasms
- Interventions
- CP-751,871; exemestane; exemestane; Fulvestrant
- Participants
- 219
- Sites
- 62
- Countries
- Argentina, Belgium, Brazil, Canada, Italy, Netherlands, Sweden, United Kingdom, United States
Trials that died the same way
- Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
“This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.” - COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
“The study was closed due to continued enrollment hurdles.” - Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
“Study closed before total enrollment met.” - Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
“Study closed due to lack of patient enrollment.” - Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
“Study was closed June 23, 2008 due to low enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.